Ivana Pavik
Overview
Explore the profile of Ivana Pavik including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
287
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Petzold K, Poster D, Krauer F, Spanaus K, Andreisek G, Nguyen-Kim T, et al.
PLoS One
. 2015 Apr;
10(4):e0123555.
PMID: 25875363
Background: Autosomal dominant polycystic kidney disease (ADPKD) is characterized by a decline in renal function at late disease stage when the majority of functional renal parenchyma is replaced by cystic...
2.
Spichtig D, Zhang H, Mohebbi N, Pavik I, Petzold K, Stange G, et al.
Kidney Int
. 2014 Jan;
85(6):1340-50.
PMID: 24402093
Fibroblast growth factor 23 (FGF23) regulates phosphate homeostasis and is linked to cardiovascular disease and all-cause mortality in chronic kidney disease. FGF23 rises in patients with CKD stages 2-3, but...
3.
Pavik I, Jaeger P, Ebner L, Wagner C, Petzold K, Spichtig D, et al.
Nephrol Dial Transplant
. 2012 Nov;
28(2):352-9.
PMID: 23129826
Background: Klotho and fibroblast growth factor 23 (FGF23) are key regulators of mineral metabolism in renal insufficiency. FGF23 levels have been shown to increase early in chronic kidney disease (CKD);...
4.
Haller M, Amatschek S, Wilflingseder J, Kainz A, Bielesz B, Pavik I, et al.
PLoS One
. 2012 Aug;
7(7):e39229.
PMID: 22859939
The vast majority of glomerular filtrated phosphate is reabsorbed in the proximal tubule. Posttransplant phosphaturia is common and aggravated by sirolimus immunosuppression. The cause of sirolimus induced phosphaturia however remains...
5.
Pavik I, Jaeger P, Ebner L, Poster D, Krauer F, Kistler A, et al.
Clin J Am Soc Nephrol
. 2011 Dec;
7(2):248-57.
PMID: 22193235
Background And Objectives: Fibroblast growth factor 23 (FGF23) levels are elevated in patients with autosomal dominant polycystic kidney disease (ADPKD) and X-linked hypophosphatemia (XLH), but only the latter is characterized...
6.
Pavik I, Jaeger P, Kistler A, Poster D, Krauer F, Cavelti-Weder C, et al.
Kidney Int
. 2010 Oct;
79(2):234-40.
PMID: 20944552
Fibroblast growth factor 23 (FGF23) and parathyroid hormone blood levels rise following progressive loss of renal function. Here we measured parameters of phosphate metabolism in 100 patients with autosomal dominant...
7.
Serra A, Kistler A, Poster D, Krauer F, Senn O, Raina S, et al.
Nephrol Dial Transplant
. 2009 Jun;
24(11):3334-42.
PMID: 19525519
Background: We initiated a randomized controlled clinical trial to assess the effect of sirolimus on disease progression in patients affected by autosomal dominant polycystic kidney disease (ADPKD). Here we report...